Page 351 - ATP-P 11th Ed
P. 351
Indications: As a topical optic anesthetic (may aid in ocular exam to relieve blepharo-
spasm); removal of foreign bodies.
Dose:
• 1 or 2 drops – 2–3min before procedure.
• See appropriate TMEP
Contraindications: Not for prolonged use.
Pregnancy Category C
Side-effects:
• Stinging
• Tearing
• Swelling
• Sensitivity to light
Adverse reactions:
• Conjunctival redness
• Transient eye pain
• Hypersensitivity reactions
TMEP use: Corneal Abrasion, Corneal Ulcer, Conjunctivitis Protocol SECTION 3
®
Toradol – See Ketorolac
®
Tranexamic Acid (TXA) (Cyklokapron )
Class: Antifibrinolytic agent
Action: Competitive inhibitor of plasminogen activation → stabilizes clots.
Indications: (Off label) Combat casualties at high risk for requiring massive blood transfu-
sion (e.g., presenting with hemorrhagic shock, penetrating torso trauma, multiple major
amputation, or clinical evidence of severe blood loss).
Dose: Adult 1g IV/IO for 2 doses
K9 Dose: 10–15 mg/kg IV
Contraindications:
• Subarachnoid hemorrhage
• Active intravascular clotting
• Known hypersensitivity
Pregnancy Category B
Side-effects:
• Cardiovascular – angina pectoris, chest pain, hypotension, myocardial infarction, pos-
tural hypotension, tachycardia
• Digestive – dose-related nausea, vomiting, and diarrhea
• Ophthalmologic – blurred vision, conjunctivitis (including conjunctival hyperemia), eye
pain, color blindness
ATP-P Handbook 11th Edition 341

